Atlas Trials

Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer

Clinical trial NCT06195254 · COMPLETED

Trial details

NCT number
NCT06195254
Sponsor
Peking University Third Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Stereotactic Body RadiotherapyPD-1 InhibitorsPancreatic Cancer
Start date
2020-12-01
Primary completion
2023-05-21
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.